Skip to content

Efficacy of Aromatic Ammonia Inhalation for Nausea Among Patients in the Emergency Department: A Randomized Controlled Trial

Efficacy of Aromatic Ammonia Inhalation for Nausea AmongPatients in the Emergency Department:A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250808003
Enrollment
52
Registered
2025-08-08
Start date
2020-09-05
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients presenting to the emergency department with nausea Nausea Ammonia Inhalation

Interventions

Place 3 milliliters of either 10% concentrated ammonia solution onto a sterile 2x2 inch gauze pad, then seal it in an opaque foil zip lock bag bag measuring 8.5 x 14 centimeters. Hold the gauze pad 2.
Experimental Drug,Placebo Comparator Drug
Ammonia,isopropyl alcohol

Sponsors

Faculty of medicine, Vajira hospital, Navamindradhiraj university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 to 65 years 2. Nausea visual analog scale of 4 to 8 3. Emergency severity index 3 and 4 4. Able to communicate in Thai 5. No history of allergy to ammonia and isopropyl alcohol

Exclusion criteria

Exclusion criteria: 1. Nausea and vomiting caused by surgical conditions 2. Pregnancy 3. Inability to breathe through the nose 4. Received antiemetic medication within 24 hours before the start of the study 5. Ingestion of drugs or foods that may cause a disulfiram-like reaction, such as metronidazole, cephalosporins, griseofulvin, isoniazid, durian, or certain mushrooms (e.g., ink cap mushrooms Coprinus spp.) 6. Chronic lung diseases, such as asthma or emphysema 7. Altered mental status 8. History of abnormal prolonged QT interval on electrocardiogram (QT prolongation) 9. Suspected nausea and vomiting due to increased intracranial pressure

Design outcomes

Primary

MeasureTime frame
nausea visual analog at minute 0, minute 2, minute 4, minute 10, and minute 15 after inhalation nausea visual analog

Secondary

MeasureTime frame
adverse effects 15 minutes after imhalation symptoms

Countries

Thailand

Contacts

Public Contactsupa niruntarai

Navamindradhiraj university

sniruntarai@gmail.com0894119112

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026